中华麻醉学杂志2024,Vol.44Issue(12) :1460-1463.DOI:10.3760/cma.j.cn131073.20240710.01212

年龄因素对咪达唑仑口服溶液用于腹股沟疝患儿疝囊高位结扎术前镇静效力的影响

Effect of age factor on preoperative sedative potency of midazolam oral solution in pediatric patients with inguinal hernia undergoing high ligation of hernial sac

杨泽雯 乔宝江 胡伟 王建设 张莉
中华麻醉学杂志2024,Vol.44Issue(12) :1460-1463.DOI:10.3760/cma.j.cn131073.20240710.01212

年龄因素对咪达唑仑口服溶液用于腹股沟疝患儿疝囊高位结扎术前镇静效力的影响

Effect of age factor on preoperative sedative potency of midazolam oral solution in pediatric patients with inguinal hernia undergoing high ligation of hernial sac

杨泽雯 1乔宝江 1胡伟 1王建设 1张莉1
扫码查看

作者信息

  • 1. 南京医科大学附属儿童医院麻醉科 南京医科大学儿科学院,南京 210008
  • 折叠

摘要

目的 评价年龄因素对咪达唑仑口服溶液用于腹股沟疝患儿疝囊高位结扎术前镇静效力的影响.方法 本研究为前瞻性研究.择期全身麻醉下腹腔镜腹股沟疝疝囊高位结扎术患儿,年龄1~6岁,性别不限,ASA分级Ⅰ或Ⅱ级,术前父母分离焦虑量表(PSAS)评分≥3分.根据年龄将患儿分为A组(1岁≤年龄<4岁)和B组(4岁≤年龄≤6岁).采用序贯法进行试验,咪达唑仑口服溶液初始剂量为0.50 mg/kg,若患儿出现阳性反应则下一例剂量增加0.05 mg/kg,若为阴性反应则下一例剂量减少0.05 mg/kg.以出现阳性反应的前一例患儿为第1例,重复此过程,直到出现7个转折点.阳性反应定义为口服咪达唑仑口服溶液30 min后患儿PSAS评分≥3分.采用probit回归法计算2组患儿咪达唑仑口服溶液用于腹股沟疝患儿疝囊高位结扎术前镇静的半数有效剂量(ED50)及其95%置信区间(CI).结果 本研究共纳入患儿49例,A组24例,B组25例.A组咪达唑仑口服溶液用于腹股沟疝患者疝囊高位结扎术前镇静的ED50为 0.628 mg/kg(95%CI 0.614~0.643 mg/kg),B 组患儿 ED50为 0.385 mg/kg(95%CI0.361~0.412 mg/kg).A 组 ED50高于 B 组(P≤0.05).结论 咪达唑仑口服溶液用于4~6岁患儿腹股沟疝疝囊高位结扎术前镇静的效力优于1~<4岁患儿.

Abstract

Objective To evaluate the effect of age factor on preoperative sedative potency of mid-azolam oral solution in pediatric patients with inguinal hernia undergoing high ligation of the hernial sac.Methods This was a prospective study.American Society of Anesthesiologists Physical Status classification Ⅰ or Ⅱ pediatric patients of either sex with inguinal hernia,aged 1-6 yr,with preoperative Parental Separa-tion Anxiety Scale score≥3,undergoing elective laparoscopic high ligation of the hernia sac with general anesthesia,were divided into group A(1 yr≤age<4 yr)and group B(4 yr≤age≤6 yr)based on age.The trial was performed using a sequential method,with an initial midazolam oral solution set at 0.50 mg/kg.If the response was positive,the dose was increased by 0.05 mg/kg in the next patient,or con-versely if negative,the dose was decreased by 0.05 mg/kg in the next patient.The child who preceded the one that exhibited a positive response served as the first case,and this process was repeated until 7 turning points were reached.A positive response was defined as a PSAS score of ≥3 measured at 30 min after oral administration of midazolam oral solution.The probit method was used to calculate the median-effective dose(ED50)and 95%confidence interval(CI)of midazolam oral solution for preoperative sedation in pediatric patients with inguinal hernia undergoing high ligation of the hernial sac in both groups.Results A total of 49 children were ultimately included in this study,with 24 in group A and 25 in group B.The ED50 of mid-azolam oral solution for preoperative sedation was 0.628 mg/kg(95%CI 0.614-0.643 mg/kg)in group A and 0.385 mg/kg(95%CI 0.361-0.412 mg/kg)in group B.The ED50 was significantly higher in group A than in group B(P≤0.05).Conclusions The potency of midazolam oral solution for preoperative sedation in pediatric patients aged 4-6 yr is superior to that in pediatric patients aged 1-<4 yr with inguinal hernia undergoing high ligation of the hernial sac.

关键词

咪达唑仑/焦虑/儿童/剂量效应关系,药物

Key words

Midazolam/Anxiety/Child/Dose-response relationship,drug

引用本文复制引用

出版年

2024
中华麻醉学杂志
中华医学会

中华麻醉学杂志

CSTPCDCSCD北大核心
影响因子:1.235
ISSN:0254-1416
段落导航相关论文